Case Study: Pfizer achieves 500,000 hours back to employees and ~88% faster clinical trial data processing with SS&C Blue Prism

How Pfizer has Scaled RPA to Deliver Breakthroughs that Change Patients’ Lives

Pfizer faced the need to scale robotic process automation across finance, HR, manufacturing and—critically—clinical and safety workflows as volumes surged during the COVID‑19 response. Manual, time‑consuming tasks such as processing large amounts of clinical trial data and validating product claim sources were bottlenecks to speed and quality. To accelerate automation at enterprise scale, Pfizer partnered with SS&C Blue Prism and deployed the Blue Prism intelligent automation platform and digital workers.

SS&C Blue Prism’s digital workers automated high‑volume clinical trial data processing and claim source validation, enabling ~88% faster processing for select clinical trial data, a 35% reduction in time to process product claim validation, and returning 500,000 hours annually to employees (including 30,000 hours saved each year on claim validation). The solution also supported rapid, compliant handling of COVID‑19 vaccine safety reports, improved review consistency and quality, and freed staff to focus on higher‑value work.

Pfizer

Namita Pande

Enterprise Automation Team Intake and Portfolio Lead